MONROVIA, Liberia (August 14, 2014) The last known doses of an experimental Ebola drug are now in the West African country of Liberia where health officials now face an excruciating choice, as they try to decide on the few Ebola patients who will get the drug.
The government had already said two doctors would be among those receiving the treatment, but it's not clear who else will get it.
"We are definitely going to be focusing on medical staff,” one official said.
The California company that developed the drug ZMapp said it will take months to build up even a modest supply.
Only two Americans and a Spaniard have received the drug, so far.
The Americans are improving, but it is unclear what role the drug has played.
The Spaniard died.
According to the World Health Organization, Ebola has killed more than half of the nearly 2,000 people who've been sickened in the current outbreak.
Nigeria's health minister announced Thursday that there's another Ebola case in Africa's most populous country, bringing the total confirmed cases there to 11.